We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain

News   Nov 13, 2009

 
Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
 
 
 

RELATED ARTICLES

Blindness Prevented in Animal Models of Retinal Degeneration

News

Using a novel patient-specific stem cell-based therapy, blindness was prevented in animal models of geographic atrophy, the advanced 'dry' form of age-related macular degeneration (AMD), which is a leading cause of vision loss among people age 65 and older.

READ MORE

Yeast Model of Metabolic Disorders May Lead to Novel Therapies

News

Researchers suggests that the role of yeast, the world's most basic eukaryotic unicellular organism, may pave the way for the development of novel, more effective therapies for the treatment of metabolic disorders.

READ MORE

Unlocking the Secret to Gene Activation

News

Researchers have made a major discovery about how “DNA binding proteins” latch onto the human genome at particular places to turn genes on or off.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE